A
Apogee Therapeutics Inc
NASDAQ:APGE
Apogee Therapeutics Inc
NASDAQ:APGE
Price:
132.91
USD
0.11%
Market Closed
Market Cap:
$10B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Apogee Therapeutics Inc
NASDAQ:APGE
|
US |
|
Absa Group Ltd
F:AU61
|
ZA |
|
C
|
Caterpillar Inc
XHAM:CAT1
|
US |
|
Y
|
Yamada Holdings Co Ltd
F:YME
|
JP |
|
M
|
Matas A/S
SWB:1MTA
|
DK |
|
P
|
Parker-Hannifin Corp
DUS:PAR
|
US |
|
Bright Horizons Family Solutions Inc
NYSE:BFAM
|
US |
|
N
|
Next PLC
F:NXG
|
UK |
|
Dabur India Ltd
NSE:DABUR
|
IN |
|
Clear Channel Outdoor Holdings Inc
NYSE:CCO
|
US |
Multiples-Based Value
The Multiples-Based Value for Apogee Therapeutics Inc (APGE) under the Base Case is hidden USD. Compared with the current market price of 132.91 USD, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
APGE Multiples-Based Value
LOCKED
